Genetically Modified Neural Stem Cells with Flucytosine and Leucovorin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified Neural Stem Cells with Flucytosine and Leucovorin, covering 2021-09-29 to 2021-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas [Phase 1]